Loading clinical trials...

RECRUITINGNA

Performance of the Paragit Sleeve to Measure and Monitor Motor Symptoms in Patients With Parkinson's Disease

An Open Multi-centre Investigation to Evaluate the Performance of the Paragit Sleeve With build-in sEMG Sensors, Kinetic Sensors, and Smart-textile to Measure and Monitor Motor Symptoms and Treatment-induced Dyskinesia in Patients With Parkinson's Disease

NCT06490861•Paragit ApS

View on ClinicalTrials.gov

Summary

This investigation is undertaken to: * Evaluate the accuracy and reliability of the device in measuring and recording motor symptoms associated with Parkinson's Disease (PD), and * To assess the safety and tolerability of the device in patients with PD.

Eligibility

Age

50 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Parkinson disease: Clinically diagnosed
•2. Age ≥ 50 (not in the childbearing aged as defined by Statistics Denmark, 15-49)
•3. Experiencing at least two of following symptoms and/or side effect on a daily basis:
•* Rigidity
•* Tremor
•* Bradykinesia
•* Dyskinesia (treatment side effect)
•4. Provision of informed consent, i.e., the subject must be able to:
•* Read and understand the Patient Information and Consent Form
•* Sign the Patient Information and Consent Form.

Exclusion Criteria

•1. Known allergy/hypersensitivity to any material in direct contact with the skin (stainless steel, silicone and polyester)
•2. MMSE \<24
•3. Other neurological diseases

Locations (1)

Hospital Beata María Ana

Madrid, Spain

Key Dates

Start Date

December 19, 2023

Primary Completion Date

August 1, 2024

Completion Date

December 31, 2024

Last Updated

July 8, 2024

Enrollment

ESTIMATED participants

Conditions

Parkinson Disease

Interventions

Paragit

DEVICE

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

NCT06692920

Parkinson Disease

View study

RECRUITINGPHASE1

[18F]F-DOPA Imaging in Patients With Autonomic Failure

NCT04246437

Autonomic FailurePure Autonomic Failure+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 8, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Performance of the Paragit Sleeve to Measure and Monitor Motor Symptoms in Patients With Parkinson's Disease

Inclusion Criteria

Exclusion Criteria

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Montelukast in Parkinson Disease

Exercise for Cognitive Excellence in Parkinson's Disease

The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations